Published in Nat Commun on October 21, 2014
The Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the Composition and Structure of Biphasic Calcium Phosphates. PLoS One (2015) 0.81
Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation. J Bone Miner Res (2015) 0.79
Deletion of Rac in Mature Osteoclasts Causes Osteopetrosis, an Age-Dependent Change in Osteoclast Number, and a Reduced Number of Osteoblasts In Vivo. J Bone Miner Res (2015) 0.78
Calcitonin physiology, saved by a lysophospholipid. J Bone Miner Res (2015) 0.77
Bone: Key role for S1P in bone remodelling. Nat Rev Endocrinol (2014) 0.75
Differential effects of Calca-derived peptides in male mice with diet-induced obesity. PLoS One (2017) 0.75
Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential. Expert Opin Ther Targets (2017) 0.75
Calcitonin receptor expression in medullary thyroid carcinoma. PeerJ (2017) 0.75
Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis. Oncogene (2017) 0.75
Increased sphingosine-1-phosphate production in response to osteocyte mechanotransduction. Bone Rep (2017) 0.75
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
How many drug targets are there? Nat Rev Drug Discov (2006) 14.22
Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res (1999) 12.83
A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res (1995) 12.21
Osteoporosis: now and the future. Lancet (2011) 5.81
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov (2010) 5.55
Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell (1996) 4.55
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab (2006) 4.33
Skeletal remodeling in health and disease. Nat Med (2007) 4.31
Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev (1995) 4.11
Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol (2010) 3.26
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature (2009) 2.79
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A (2008) 2.39
The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science (2008) 2.35
G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood (2003) 2.27
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev (2010) 2.10
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest (2013) 2.08
A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Genesis (2001) 2.08
Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med (2011) 2.00
Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem (2001) 1.94
Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab (2010) 1.79
Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis. Crit Care Med (2008) 1.67
Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J (2006) 1.63
Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol (2009) 1.55
THYROID ORIGIN OF CALCITONIN. Nature (1964) 1.55
The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest (2012) 1.54
A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet (2005) 1.50
Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis (2001) 1.46
Mouse phenotyping. Methods (2010) 1.43
Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One (2009) 1.42
Osteogenesis imperfecta. Best Pract Res Clin Rheumatol (2008) 1.41
Molecular mechanisms in coupling of bone formation to resorption. Crit Rev Eukaryot Gene Expr (2009) 1.34
Calcitonin receptors of kidney and bone. Science (1972) 1.32
Insights into the pharmacological relevance of lysophospholipid receptors. Br J Pharmacol (2012) 1.31
Progress, paradox, and potential: parathyroid hormone research over five decades. Ann N Y Acad Sci (2007) 1.31
The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. J Biol Chem (2010) 1.29
Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. J Cell Biol (2013) 1.24
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest (2002) 1.24
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone (2010) 1.21
Predictors of survival in sepsis: what is the best inflammatory marker to measure? Curr Opin Infect Dis (2012) 1.16
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol (2004) 1.12
Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci (1999) 1.08
Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone. J Mol Med (Berl) (2009) 1.06
Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet (2008) 1.06
Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner Res (2004) 1.05
Paget's disease of bone: histologic analysis of 754 patients. J Bone Miner Res (2009) 1.05
Cell cycle-dependent coupling of the calcitonin receptor to different G proteins. Science (1991) 1.03
A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization. J Cell Biol (2011) 1.02
Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. J Bone Miner Res (2011) 1.02
The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J Clin Endocrinol Metab (1983) 1.01
Calcitonin deficiency in mice progressively results in high bone turnover. J Bone Miner Res (2006) 0.99
Calcitonin-a hormone from the parathyroid which lowers the calcium-level of the blood. Nature (1962) 0.97
The role of calcitonin and alpha-calcitonin gene-related peptide in bone formation. Arch Biochem Biophys (2008) 0.95
Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. J Bone Miner Res (2008) 0.92
Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol (1995) 0.91
Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med (1987) 0.91
Osteoclasts, no longer osteoblast slaves. Nat Med (2006) 0.90
A cloned porcine renal calcitonin receptor couples to adenylyl cyclase and phospholipase C. Am J Physiol (1992) 0.89
Calcitonin: physiology or fantasy? J Bone Miner Res (2013) 0.87
Calcitonin and bone formation: a knockout full of surprises. J Clin Invest (2002) 0.86
Calcitonin, an enigmatic hormone: does it have a function? J Musculoskelet Neuronal Interact (2001) 0.81
Calcitonin induces expression of the inducible cAMP early repressor in osteoclasts. Endocrine (2008) 0.81
Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism. Endocrinology (1996) 0.80
Control of bone formation by the serpentine receptor Frizzled-9. J Cell Biol (2011) 1.77
Osteopetrosis, osteopetrorickets and hypophosphatemic rickets differentially affect dentin and enamel mineralization. Bone (2012) 0.92
eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription. Nat Commun (2015) 0.86
Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts. Sci Transl Med (2016) 0.84
Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton. Bone (2016) 0.78
Spine Metastases in Immunocompromised Mice after Intracardiac Injection of MDA-MB-231-SCP2 Breast Cancer Cells. Cancers (Basel) (2022) 0.75